160 related articles for article (PubMed ID: 26061806)
1. Correlation between long-term outcome and steroid therapy in type 1 autoimmune pancreatitis: relapse, malignancy and side effect of steroid.
Shimizu S; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Hirata Y; Takada H; Ohara H; Joh T
Scand J Gastroenterol; 2015; 50(11):1411-8. PubMed ID: 26061806
[TBL] [Abstract][Full Text] [Related]
2. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
Miyazawa M; Takatori H; Shimakami T; Kawaguchi K; Kitamura K; Arai K; Matsuda K; Sanada T; Urabe T; Inamura K; Kagaya T; Mizuno H; Fuchizaki U; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
PLoS One; 2017; 12(11):e0188549. PubMed ID: 29166415
[TBL] [Abstract][Full Text] [Related]
4. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience.
Hart PA; Topazian MD; Witzig TE; Clain JE; Gleeson FC; Klebig RR; Levy MJ; Pearson RK; Petersen BT; Smyrk TC; Sugumar A; Takahashi N; Vege SS; Chari ST
Gut; 2013 Nov; 62(11):1607-15. PubMed ID: 22936672
[TBL] [Abstract][Full Text] [Related]
5. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment.
Hirano K; Tada M; Isayama H; Yagioka H; Sasaki T; Kogure H; Nakai Y; Sasahira N; Tsujino T; Yoshida H; Kawabe T; Omata M
Gut; 2007 Dec; 56(12):1719-24. PubMed ID: 17525092
[TBL] [Abstract][Full Text] [Related]
7. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
[TBL] [Abstract][Full Text] [Related]
8. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.
Kim HM; Chung MJ; Chung JB
Pancreas; 2010 Jul; 39(5):555-60. PubMed ID: 20182397
[TBL] [Abstract][Full Text] [Related]
9. Predictive Factors for Autoimmune Pancreatitis Relapse After 3 Years of Maintenance Therapy.
Nakamura A; Ozawa M; Watanabe T; Ito T; Muraki T; Hamano H; Koinuma M; Kawa S
Pancreas; 2018; 47(10):1337-1343. PubMed ID: 30286015
[TBL] [Abstract][Full Text] [Related]
10. Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China.
Xin L; Meng QQ; Hu LH; Lin H; Pan J; Hao L; Liu PP; Qian W; Wang LW; Li ZS
Pancreas; 2018 Oct; 47(9):1110-1114. PubMed ID: 30142120
[TBL] [Abstract][Full Text] [Related]
11. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis.
Park DH; Kim MH; Oh HB; Kwon OJ; Choi YJ; Lee SS; Lee TY; Seo DW; Lee SK
Gastroenterology; 2008 Feb; 134(2):440-6. PubMed ID: 18155707
[TBL] [Abstract][Full Text] [Related]
12. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study.
Sugimoto M; Takagi T; Suzuki R; Konno N; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Asama H; Takasumi M; Hikichi T; Watanabe H; Obara K; Ohira H
PLoS One; 2015; 10(9):e0138604. PubMed ID: 26381760
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.
Kubota K; Kamisawa T; Hirano K; Hirooka Y; Uchida K; Ikeura T; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Okazaki K; Kawa S; Shimosegawa T; Takeyama Y; Chiba T
J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):223-230. PubMed ID: 29430861
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Long-term Maintenance Steroid Therapy Cessation in Patients With Autoimmune Pancreatitis: A Prospective Study.
Hirano K; Tada M; Isayama H; Sasahira N; Umefune G; Akiyama D; Watanabe T; Saito T; Takagi K; Takahara N; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Yamamoto N; Nakai Y; Arizumi T; Toda N; Koike K
J Clin Gastroenterol; 2016 Apr; 50(4):331-7. PubMed ID: 26565969
[TBL] [Abstract][Full Text] [Related]
16. Management strategies for autoimmune pancreatitis.
Kamisawa T; Takuma K; Hara S; Tabata T; Kuruma S; Inaba Y; Gopalakrishna R; Egawa N; Itokawa F; Itoi T
Expert Opin Pharmacother; 2011 Oct; 12(14):2149-59. PubMed ID: 21711086
[TBL] [Abstract][Full Text] [Related]
17. Relative Rise of Serum IgG4 Levels After Steroid Therapy for Autoimmune Pancreatitis Predicts the Likelihood of Relapse.
Suzuki D; Shimizu K; Tokushige K
Pancreas; 2018 Apr; 47(4):412-417. PubMed ID: 29517627
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategy for autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcome of lung involvement in IgG4-related autoimmune pancreatitis.
Ogoshi T; Kido T; Yatera K; Oda K; Nishida C; Yamasaki K; Orihashi T; Kawanami Y; Ishimoto H; Taguchi M; Harada M; Mukae H
Respirology; 2015 Oct; 20(7):1142-4. PubMed ID: 26182953
[TBL] [Abstract][Full Text] [Related]
20. Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.
Ohno Y; Kumagi T; Yokota T; Azemoto N; Tanaka Y; Tange K; Inada N; Miyata H; Imamura Y; Koizumi M; Kuroda T; Hiasa Y;
Orphanet J Rare Dis; 2016 Jul; 11(1):103. PubMed ID: 27465035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
